Sotac Pharmaceuticals Limited (NSE: SOTAC)
India
· Delayed Price · Currency is INR 109.50
-5.40 (-4.70%)
At close: Dec 20, 2024
Sotac Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Net Income | 44.6 | 42.81 | 28.79 | 28.79 | -23.65 | 0.88 |
| Depreciation & Amortization | 31.94 | 30.95 | 22.76 | 11.26 | 25.93 | 13.99 |
| Other Amortization | 0.05 | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.47 |
| Loss (Gain) From Sale of Investments | -1.29 | -1.29 | - | 18.36 | - | - |
| Other Operating Activities | 6.05 | -30.65 | 14.13 | 4.24 | 10.72 | 6.48 |
| Change in Accounts Receivable | -7.23 | -115.47 | 38.11 | -62.71 | 5.66 | -34.9 |
| Change in Inventory | 6.14 | -43.68 | -44.65 | -15.96 | -25.06 | -2.5 |
| Change in Accounts Payable | 47.11 | 35 | -47.85 | 94.27 | 16.28 | 46.11 |
| Change in Other Net Operating Assets | -41.86 | -78.95 | 70.12 | -14.76 | -12.94 | -29.02 |
| Operating Cash Flow | 85.52 | -161.22 | 81.43 | 63.51 | -3.07 | 0.57 |
| Operating Cash Flow Growth | - | - | 28.22% | - | - | - |
| Capital Expenditures | -146.36 | -177.89 | -90 | -35.04 | -31.61 | -98.01 |
| Sale of Property, Plant & Equipment | 0.13 | 0.09 | 13.14 | - | - | - |
| Investment in Securities | -61.79 | -20.96 | -40.02 | -0.59 | -1.29 | -19.89 |
| Other Investing Activities | 4.66 | 1.8 | 0.46 | 0.48 | 0.6 | 0.42 |
| Investing Cash Flow | -185.42 | -196.79 | -116.74 | -35.15 | -32.3 | -117.49 |
| Short-Term Debt Issued | - | - | 31.07 | 24.56 | 22.67 | 64.28 |
| Long-Term Debt Issued | - | 43.62 | 6.54 | - | 19.27 | - |
| Total Debt Issued | 79.68 | 43.62 | 37.61 | 24.56 | 41.94 | 64.28 |
| Short-Term Debt Repaid | - | -15.42 | - | - | - | - |
| Long-Term Debt Repaid | - | - | - | -17.48 | - | -6.79 |
| Total Debt Repaid | -9.98 | -15.42 | - | -17.48 | - | -6.79 |
| Net Debt Issued (Repaid) | 69.7 | 28.2 | 37.61 | 7.08 | 41.94 | 57.49 |
| Issuance of Common Stock | - | 333 | 112.66 | - | - | 52.5 |
| Common Dividends Paid | - | - | - | -4.6 | - | - |
| Other Financing Activities | 20.81 | -65.83 | -18.9 | -30.78 | -8.17 | 3.99 |
| Financing Cash Flow | 90.52 | 295.37 | 131.36 | -28.3 | 33.78 | 113.98 |
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | - | - | - |
| Net Cash Flow | -9.39 | -62.64 | 96.05 | 0.05 | -1.59 | -2.94 |
| Free Cash Flow | -60.84 | -339.11 | -8.57 | 28.46 | -34.68 | -97.44 |
| Free Cash Flow Margin | -5.80% | -32.63% | -1.11% | 3.89% | -7.10% | -34.07% |
| Free Cash Flow Per Share | -5.51 | -30.89 | -1.06 | 3.54 | -4.31 | -28.10 |
| Cash Interest Paid | 16.29 | 15.23 | 18.64 | 5.32 | 10.24 | 3.27 |
| Cash Income Tax Paid | 6.77 | 20.89 | 16.84 | 18.59 | 4.21 | 2.49 |
| Levered Free Cash Flow | -31.01 | -323.71 | -54.33 | -10.71 | -27.84 | - |
| Unlevered Free Cash Flow | -20.65 | -314.02 | -42.44 | -7.57 | -21.61 | - |
| Change in Net Working Capital | -59.23 | 202.89 | 8.43 | 26.62 | 8.82 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.